AI assistant
GlaxoSmithKline PLC — Director's Dealing 2015
Oct 2, 2015
5262_dirs_2015-10-02_6d0a4374-49a0-48b2-8e98-4cd716931583.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 1107B
GlaxoSmithKline PLC
02 October 2015
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons
In accordance with DTR 3.1.4R(1)(a) GlaxoSmithKline plc ('GSK') was advised on 2 October 2015 that the following Directors and Persons Discharging Managerial Responsibilities acquired GSK Ordinary Shares ('Shares') on 1 October 2015, at a price of 1292.48 pence per Share, as a result of the reinvestment of dividends paid on Shares held through GSK's ShareReward Plan (the 'Plan'):
| Director/PDMR | Ordinary Shares |
| Sir Andrew Witty | 45 |
| Mr R G Connor | 55 |
| Mr S Dingemans | 15 |
| Mr N Hirons | 3 |
| Mr S A Hussain | 10 |
| Mr D S Redfern | 63 |
| Ms C Thomas | 63 |
| Mr P C Thomson | 32 |
| Dr P J T Vallance | 36 |
| Ms E Walmsley | 10 |
| Mrs V A Whyte | 43 |
V A Whyte
Company Secretary
2 October 2015
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSXLLFBEBFXFBL